Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B +Rule 4.7B Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B Introduced 31/03/00 Amended 30/09/01, 24/10/05, 17/12/10, 01/09/16

report for entities subject to Listing Rule 4.7B

Quarterly report for entities subject to Listing Rule 4.7B

Introduced 31/03/00 Amended 30/09/01, 24/10/05, 17/12/10, 01/09/16

Name of entity

Immutep Limited

ABN		Quarter ended ( current quarter )
90 009 237 889		31 st March 2018

Consolidated statement of cash flows	Current quarter $A 000	Year to date (9 months) $A 000
1.	Cash flows from operating activities	1,619		2,958
1.1	Receipts from customers
1.2	Payments for	(1,478	)	(5,662	)
	(a) research and development
	(b) product manufacturing and operating costs
	(c) advertising and marketing	(54	)	(185	)
	(d) leased assets
	(e) staff costs	(784	)	(2,370	)
	(f) administration and corporate costs	(986	)	(1,849	)
1.3	Dividends received (see note 3)
1.4	Interest received	15		41
1.5	Interest and other costs of finance paid
1.6	Income taxes paid
1.7	Government grants and tax incentives	687		2,004
1.8	Other (provide details if material)
1.9	Net cash from / (used in) operating activities	(981	)	(5,063	)
2.	Cash flows from investing activities			(3	)
2.1	Payments to acquire:
	(a) property, plant and equipment
	(b) businesses (see item 10)
	(c) investments

Quarterly report for entities subject to Listing Rule 4.7B

Consolidated statement of cash flows	Current quarter $A 000	Year to date (9 months) $A 000
	(d) intellectual property
	(e) other non-current assets
2.2	Proceeds from disposal of:
	(a) property, plant and equipment
	(b) businesses (see item 10)
	(c) investments
	(d) intellectual property
	(e) other non-current assets
2.3	Cash flows from loans to other entities
2.4	Dividends received (see note 3)
2.5	Other (provide details if material)
2.6	Net cash from / (used in) investing activities			(3	)
3.	Cash flows from financing activities
3.1	Proceeds from issues of shares	6,850		13,412
3.2	Proceeds from issue of convertible notes
3.3	Proceeds from exercise of share options
3.4	Transaction costs related to issues of shares, convertible notes or options	(3	)	(1,157	)
3.5	Proceeds from borrowings
3.6	Repayment of borrowings
3.7	Transaction costs related to loans and borrowings
3.8	Dividends paid
3.9	Other (provide details if material)
3.10	Net cash from / (used in) financing activities	6,847		12,255
4.	Net increase / (decrease) in cash and cash equivalents for the period
4.1	Cash and cash equivalents at beginning of quarter/year to date	13,702		12,295
4.2	Net cash from / (used in) operating activities (item 1.9 above)	(981	)	(5,063	)
4.3	Net cash from / (used in) investing activities (item 2.6 above)			(3	)
4.4	Net cash from / (used in) financing activities (item 3.10 above)	6,847		12,255

Quarterly report for entities subject to Listing Rule 4.7B

Consolidated statement of cash flows	Current quarter $A 000		Year to date (9 months) $A 000
4.5	Effect of movement in exchange rates on cash held		439			523
4.6	Cash and cash equivalents at end of quarter		20,007			20,007
5.	Reconciliation of cash and cash equivalents at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts	Current quarter $A 000			Previous quarter $A 000
5.1	Bank balances		8,703			6,699
5.2	Call deposits		813			1,608
5.3	Bank overdrafts
5.4	Other (term deposit)		10,491			5,395
5.5	Cash and cash equivalents at end of quarter (should equal item 4.6 above)		20,007			13,702
6.	Payments to directors of the entity and their associates		Current quarter $A 000
6.1	Aggregate amount of payments to these parties included in item 1.2			125
6.2	Aggregate amount of cash flow from loans to these parties included in item 2.3
6.3	Include below any explanation necessary to understand the transactions included in items 6.1 and 6.2
Directors fees and consulting fees at normal commercial rates
7.	Payments to related entities of the entity and their associates		Current quarter $A 000
7.1	Aggregate amount of payments to these parties included in item 1.2
7.2	Aggregate amount of cash flow from loans to these parties included in item 2.3
7.3	Include below any explanation necessary to understand the transactions included in items 7.1 and 7.2

Quarterly report for entities subject to Listing Rule 4.7B

8.	Financing facilities available Add notes as necessary for an understanding of the position	Total facility amount at quarter end $A 000	Amount drawn at quarter end $A 000
8.1	Loan facilities
8.2	Credit standby arrangements
8.3	Other (please specify)
8.4	Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.

9.	Estimated cash outflows for next quarter	$A 000
9.1	Research and development		4,895
9.2	Product manufacturing and operating costs
9.3	Advertising and marketing		53
9.4	Leased assets
9.5	Staff costs		778
9.6	Administration and corporate costs		819
9.7	Other (provide details if material)
9.8	Total estimated cash outflows		6,545

10.	Acquisitions and disposals of business entities (items 2.1(b) and 2.2(b) above)	Acquisitions	Disposals
10.1	Name of entity
10.2	Place of incorporation or registration
10.3	Consideration for acquisition or disposal
10.4	Total net assets
10.5	Nature of business

Quarterly report for entities subject to Listing Rule 4.7B

Compliance statement

Full Press Release Details